Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen (IMPROVE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02431897
Recruitment Status : Recruiting
First Posted : May 1, 2015
Last Update Posted : May 6, 2019
Sponsor:
Collaborators:
University of Alabama at Birmingham
Women and Infants Hospital of Rhode Island
Pfizer
Information provided by (Responsible Party):
David Rahn, MD, University of Texas Southwestern Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 2020
  Estimated Study Completion Date : July 2023